PER
Click for more information
5.00% 8.4¢ percheron therapeutics limited

Ann: WHO selects proposed INN for ATL1102, page-17

  1. itsagas
    13,080 Posts.
    lightbulb Created with Sketch. 1365
    clock Created with Sketch.
    10/05/24
    12:49
    Post #: 73762861
    https://www.biospace.com/article/fda-s-accelerated-approval-of-sarepta-dmd-gene-therapy-comes-under-fire/
    PER Price at posting: 7.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
0.004(5.00%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.0¢ 8.4¢ 8.0¢ $26.89K 328.0K

Buyers (Bids)

No. Vol. Price($)
1 9602 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 58051 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.